乌鸦传媒

<乌鸦传媒 class="page-title">Oncology/Hematology

Lung Cancer

<乌鸦传媒 class="page-description">

More in Lung Cancer

New First-Line Option for Advanced ALK-Positive Lung Cancer

In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor

Dec 18, 2024
FDA APPROVED ensartinib (Ensacove) over a computer rendering of lung cancer.
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

News, features, and commentary about cancer-related issues

Dec 13, 2024
Onco Break over a computer rendering of a cancer cell.
Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk Patients

Signal largely driven by newly emerging arrhythmias

Dec 12, 2024
A computer rendering of a heart and pulse.
Industry Clinic 鈥� Ad Insights
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Dec 12, 2024
A photo of a male physician showing his male patient a tablet.
Industry Clinic 鈥� Ad Insights
Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

Dec 10, 2024
A photo of a female physician at her desk talking to her male patient.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

News, features, and commentary about cancer-related issues

Dec 05, 2024
Onco Break over a computer rendering of a cancer cell.
Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

Prevention and screening efforts accounted for 80% of those averted deaths

Dec 05, 2024
A photo of a stethoscope in the center of a circle of variously colored cancer ribbons.
Durvalumab Wins FDA Approval in Limited-Stage SCLC

Unprecedented 22.5-month improvement in median overall survival as consolidation therapy

Dec 05, 2024
FDA APPROVED durvalumab (Imfinzi) over a computer rendering of lung cancer.
FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers

Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC

Dec 04, 2024
FDA APPROVED zenocutuzumab-zbco (Bizengri) over a computer rendering of monoclonal antibodies attacking cancer cells.
Industry Clinic 鈥� Ad Insights
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

Dec 04, 2024
A computer rendering of a transparent body with a tumor in the lungs highlighted.
Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests

News, features, and commentary about cancer-related issues

Nov 29, 2024
Onco Break over a computer rendering of a cancer cell.
Early Promise for PI3K Inhibitor in Brain Metastases

Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease

Nov 25, 2024
SNO over a photo of George R. Brown Convention Center in Houston, TX.
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

News, features, and commentary about cancer-related issues

Nov 22, 2024
Onco Break over a computer rendering of a cancer cell.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer

More research needed on role of local therapy in new era of treatment

Nov 22, 2024
A computer rendering of a transparent body with the lungs and lung cancer highlighted.
More in Lung Cancer

1.00 CME Credits
Precision in Progress: Targeting the Future of Upper GI Cancers

1.00 CME Credits
Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies From Leading Experts

0.50 CME Credits
Melanoma: Expert Recommended Approaches to Selection and Sequencing of Immunotherapies

1.00 CME Credits
Critical Clues: Identifying and Managing Interstitial Lung Disease in Patients With Breast Cancer

0.75 CME Credits
Ask the Experts: Latest Advances in Treatment of Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer

1.00 CME Credits
Optimizing Adherence, Tolerability, and Persistence to Oral CLL Therapies

1.00 CME Credits
Improving Outcomes in mUC Through Real-World Insights and Expert-Led, Team-Based Planning

1.00 CME Credits
Fostering Equity in Cancer Care: Culturally Competent Approaches for LGBTQ+ Patients